Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model

AIM: To investigate the therapeutic potential of two recombinant proteins, Survivin and luteinizing hormone-releasing hormone (LHRH) fusion protein [LHRH(6leu)-LTB] for immunotherapy of breast cancer. METHODS: Murine 4T-1 breast cancer model was used to evaluate the efficacy of recombinant proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Himani, Hada, Rohit Singh, Gupta, Jagdish C, Talwar, G P, Dubey, Shweta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314864/
https://www.ncbi.nlm.nih.gov/pubmed/30622927
http://dx.doi.org/10.5306/wjco.v9.i8.188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314864/
https://www.ncbi.nlm.nih.gov/pubmed/30622927
http://dx.doi.org/10.5306/wjco.v9.i8.188

Ejemplares similares